A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

China Medical University Hospital, Taichung

Changhua Christian Hospital, Changhua

Queen Elizabeth Hospital, Kowloon

Saint Vincent's Hospital Melbourne, Fitzroy

Peninsula & South Eastern Haematology and Oncology Group, Frankston

Krankenhaus Elisabethinen Linz, Linz

Sir Charles Gairdner Hospital, Nedlands

Klinikum Klagenfurt Am Worthersee, Klagenfurt

Azienda Ospedaliero - Universitaria San Luigi Gonzaga, Orbassano

Assistance Publique-Hopitaux de Marseille Hopital Nord, Marseille

HELIOS Klinikum Emil von Behring, Berlin

Complejo Hospitalario Universitario A Coruna, A Coruña

Istituto Europeo di Oncologia, Milan

Gachon University Gil Medical Center, Incheon

USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax

Pius Hospital Oldenburg, Oldenburg

Hospital Universitario Ramon Y Cajal, Madrid

Hospital Universitario La Paz, Madrid

Levine Cancer Institute - Southpark, Charlotte

Hospital Universitario Puerta de Hierro - Majadahonda, Madrid

Chungbuk National University Hospital, Cheongju-si

Hopital Larrey, CHU de Toulouse, Service de Pneumologie, Toulouse

Florida Hospital Medical Group, Orlando

Centro di Riferimento Oncologico di Aviano, Aviano

Hopital Haut-Leveque, Pessac

Sarah Cannon Research Institute, Nashville

Taichung Veterans General Hospital, Taichung

Keimyung University Dongsan Medical Center, Daegu

Azienda Ospedaliero Universitaria di Parma, Parma

Azienda USL della Romagna, Ravenna

Barbara Ann Karmanos Cancer Institute, Detroit

Evangelisches Krankenhaus Hamm, Hamm

Washington University School of Medicine, St Louis

Centre de Lutte Contre le Cancer Centre Leon Berard, Lyon

Thoraxklinik Heidelberg gGmbH, Heidelberg

National Cheng Kung University, Tainan City

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli

Ludwig-Maximilians-Universitat Munchen, München

USOR - Rocky Mountain Cancer Centers - Pueblo, Pueblo

Klinikum Kempten-Oberallgau, Kempten (Allgäu)

Universitatsklinikum Ulm, Ulm

The Oncology Institute of Hope and Innovation, Whittier

University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange

Centre Hospitalier Intercommunal de Creteil, Créteil

Providence Portland Medical Center, Portland

Beijing Cancer Hospital, Beijing

Jilin Provincial Cancer Hospital (Changchun Cancer Hospital), Changchun

Shanghai Pulmonary Hospital, Shanghai

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Cross Cancer Institute, Edmonton

Tom Baker Cancer Center, Calgary

Toronto University Health Network, Toronto

McGill University Health Centre, Montreal

Prince of Wales Hospital, Shatin

Queen Mary Hospital, Hong Kong

Princess Margaret Hospital - Hong Kong, Kowloon

Queen Mary Hospital, Hong Kong

Azienda Ospedaliera San Camillo Forlanini, Rome

Fujita Health University Hospital, Toyoake

Kanagawa Cancer Center, Yokohama

Sendai Kousei Hospital, Sendai

Okayama University Hospital, Okayama

Kansai Medical University Hirakata Hospital, Hirakata-shi

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku

Maastricht University Medical Centre, Maastricht

Vrije Universiteit Medisch Centrum, Amsterdam

Erasmus University Medical Center, Rotterdam

National Cancer Center, Goyang-si

Korea University Anam Hospital, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Institut Catala d'Oncologia Badalona - Hospital Germans Trias i Pujol, Badalona

Hospital Universitario Vall d'Hebron, Barcelona

Skanes Universitetssjukhus i Lund, Lund

Karolinska Universitetssjukhuset, Stockholm

Uppsala Akademiska Sjukhus, Uppsala